tirzepatide cardiovascular outcomes trial 2024

tirzepatide cardiovascular outcomes trial 2024 Effects of on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity In patients with type 2

Name: tirzepatide cardiovascular outcomes trial 2024 Effects of on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity In patients with type 2
Brand: actil.am
SKU: 77094185964
Price: 21.47 USD
Availability: InStock
Rating: 4.6606000000000005 (24 reviews)

SKU: 77094185964

4.7

USD21.47 USD63.47

Pay in 4 interest-free payments of $5.37 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

Description

Red flags to watch for Any provider who prescribes without a medical evaluation, doesnt require follow-up appointments, or only offers compounded medications without discussing FDA-approved alternatives

As a phase 3 trial, this trial cannot fully explore all potential risks and adverse events associated with this medication For patients who are overweight (BMI 2530), results may be different as only a small number of patients (5.5%) were overweight in this study

10.1016/j.bbi.2018.01.009 97 KoelleD